A multitude of regulatory genes are involved in phylogenetically conserved developmental cascades required for the patterning, cell-type specification, and differentiation of specific central nervous system (CNS) structures. Here, we describe the distribution of a mouse transcript encoding a homolog of the C. elegans mab-21 gene. In the nematode tail, mab-21 is required for the short-range patterning and cell-fate determination events mediated by egl-5 and mab-18, two homeobox genes homologous to Abd-B and Pax6, respectively. In mouse midgestation embryogenesis, Mab21 is expressed at its highest levels in the rhombencephalon, cerebellum, midbrain, and prospective neural retina. Our data and the genetic interactions previously documented in the nematode suggest that Mab21 may represent a novel, important regulator of mammalian cerebellum and eye development.
Through a differential screening strategy (Consalez et al., 1996; Consalez et al., 1998) comparing RNAs extracted from various segments along the AP axis of the embryonic mouse brain, our group (Mariani et al., in preparation) has cloned one mouse homolog (GenBank AFO4O945) of the C. elegans cell fate specification gene mab-21. The nematode gene was found to be required for the choice of alternate fates by several cells in the C. elegans male tail. mab-21 mutants have additional pleiotropic phenotypes affecting body shape and fecundity, as well as motor coordination, to suggest that the gene has functions outside the tail region of male worms (Chow et al., 1995) . Mutation of mab-21 lead to cell-autonomous and non-cell-autonomous changes in the choice of specific cell fates. Mutations of egl-5 (Chow and Emmons, 1994) , a nematode homolog of Abd-B, and of mab-18 (Zhang and Emmons, 1995) , a Pax6 homolog devoid of the paired domain, lead to a phenotype identical to that caused by homozygous mab-21 mutations, suggesting genetic interactions.
Independent human genetics work led other authors to the isolation of a mab-21 homolog in adult brain cDNA (Margolis et al., 1996) . The gene (MAB21) was isolated from, and analyzed in adult tissues and it was found expressed in the cerebellum. Although no changes have been reported in the size of a CAG repeat within the MAB21 transcript in any genetically determined brain disorder, the repeat displays size variation in the normal population (Margolis et al., 1996) , as well as meiotic instability (Potter, 1997) in phenotypically normal families. These features propose MAB21 as a potential candidate gene for susceptibility to simple Mendelian or polygenic neurological disorders. 
Early expression of Mab21 in the embryo
By wholemount in situ hybridization ( Fig. 1) and RT-PCR (not shown), we determined that the onset of Mab21 expression occurs at 8.5 days post coitum (not shown). At E9.5 (Fig. 1A) , the transcript is clearly visible in the dorsal midbrain, as well as in the branchial region. No Mab21 signal is seen in the anterior head. Territories that express Mab21 at E9.5 keep transcribing the gene at E10.5 (Fig.  1B) . At this stage, the telencephalon is again negative, while signal outside the central nervous system (CNS) is observed in the limbs (fl, hl) and genital ridge (gr).
Mab21 expression in the prospective neural retina
At E9.5, signal is also detected in the retinal primordium of the optic cup (Fig. 1A) . At this stage, the optic cup undertakes invagination to generate the neural layer of the retina, while inductive interactions lead to the specification of the prospective lens. Mab21 is mainly expressed in the central portion of the optic cup (Fig. 1C,D) . Lower level signal is also visible in the optic stalk and presumptive pigmented epithelium. At E9.5, weak signal is also observed in the lens primordium (Fig. 1D ). As regards later stages, both the retina, mostly in the presumptive ganglion cell layer, and the lens, express Mab21 throughout midgestation embryogenesis ( Fig. 2C ,N,R,S).
Expression of Mab21 in midgestation brain development
Stages of development ranging from E10.5 to E14.5 were studied by in situ hybridization of tissue sections (Fig. 2) , to finely map Mab21 transcript distribution in this interval. At E10.5 ( Fig. 2A-D , negative control in Fig. 2E ), strong signal is seen at all sites observed by wholemount hybridization. High expression levels are seen in the alar mesencephalon and in the rhombencephalic basal plate ( Fig. 2A,B) , from r2 to caudal rhombomeres. A negative transversal domain was detected in the caudal mesencephalon, isthmus and r1 (Fig. 2B) . In the rhombencephalon, signal is localized in the ventricular zone, but mostly in subventricular/ mantle layer (Fig. 2D) . In the mesencephalon, the transcript appears distributed throughout the dorsal ventricular wall, along an increasing postero-anterior gradient. The posterior third of the tectum, that expresses the homeobox transcription factor En1, seems to express the gene at lower levels. The optic cup and presumptive lens also express Mab21 at high levels (Fig. 2C ). Other expression sites include the four branchial arches (Fig. 2B,D) , the genital ridge (Fig. 2B) , and the limbs ( Fig. 2A-C) . At E12.5 ( Fig. 2F -P, negative control in Fig. 2U ), the Mab21 transcript is found both in the alar and basal plates of the caudal diencephalon (p1) (arrow), and in the floor plate and tectum of the mesencephalon (mb) (Fig. 2F,H) . Fig. 2G shows a magnification of the basal plate shown in Fig. 2F . Again, in the anterior mesencephalon the gene is expressed at higher levels than in the posterior midbrain. New expression appears in the alar plates of the isthmus and r1 (Fig. 2H) . Signal in the isthmus is restricted to a thin mantle layer in the alar plate (Fig. 2H) . Strong signal is detected in alar plates of r1 and r2 (Fig. 2H) , the cerebellar plate (Fig. 2H) , and the rhombic lip (Fig. 2K,I shows a magnification of the prospective cerebellum). In the prosencephalon, signal is observed in the pretectum (p1) (Fig. 2H) , and in a restricted superficial area of the lateral ganglionic eminence (Fig. 2J,N,O) . Outside the brain, signal is observed in the maxillary region, olfactory epithelium (Fig. 2J,L) , and retina (Fig. 2N) . At the lumbar level, Fig. 2 . mRNA in situ hybridization of embryonic tissue sections at 10.5 (A-E), 12.5 (F-P,U) and 14.5 (Q-T,V) days postcoitum. Negative controls in (E,U,V). bra, branchial arch; cb, cerebellum; d, diencephalon; ge, ganglionic eminence; gr, genital ridge; hl, hindlimb bud; fl, forelimb bud; fp, floor plate; hs, hypotalamic sulcus; l, lens; max, maxilla; mb, mesencephalon; oe, olfactory epithelium; or, optic recess; r, retina; rh, rhomboencephalon; sc, spinal cord; t, telencephalon; vib, vibrissae; vo, vomeronasal organ. arrow in (F): ventral signal in midbrain, magnification in (G). In all sagittal sections, anterior is to the left. Scale bar: 500 mm in (A) refers to (A-E); in (F) refers to (F,H,J,N); in (K) refers to (K,L,U); in (Q) refers to (Q,S,T,V). Scale bar: 50 mM in (G) refers to (G,M,O,P).
Mab21 is expressed in the spinal cord (Fig. 2P) , in a region, along the DV axis, roughly superimposable to that expressing Pax3 (Goulding et al., 1993; Pituello et al., 1995) , and in the presumptive dorsal root ganglia. At E14.5 (Fig. 2Q -T, negative control in Fig. 2V ), the Mab21 transcript is detected in the dorsal midbrain and cerebellum. In the midbrain, signal is now observed throughout the dorsal wall, including the ventricular layer (Fig. 2S,T) . Other sites of expression include the hypothalamic sulcus (Fig. 2S) , the lateral ganglionic eminence (Fig. 2T) , the retina and lens (Fig. 2R,S) , the maxilla and palate (Fig. 2T) , the nasal and vomeronasal epithelium (Fig. 2S) , and the genital ridge (Fig. 2T ).
Mab21 remains expressed in the postnatal cerebellum and eye
Non-radioactive in situ hybridization of postnatal day 17 (P17) cerebellum (Fig. 3A -C, negative control in Fig. 3D ) reveals that Mab21 marks mostly the internal granular layer, while no signal is observed at the level of the Purkinje cell monolayer. Likewise, low-level or no Mab21 signal is observed in the molecular layer, inhabited mostly by fibers, astrocytes, stellate and basket cells, or in the cerebellar white matter, containing mostly fibers, astrocytes and oligodendrocytes. Northern analysis performed on adult mouse tissues (Fig. 3E) reveals that, of all districts tested, Mab21 expression is restricted to the cerebellum and eye, with lower levels in the forebrain. Persistent expression in the eye after completion of retinal development has also been reported in regard to the Xenopus Pax6 gene (Hirsch and Harris, 1997) .
Mab21 is a new mammalian gene, homologous to a nematode factor required for the proper positional and cell type specification processes mediated by two C. elegans homeobox genes, egl5, and mab18, homologous to Abd-B and Pax6, respectively. In the midgestation mouse embryo, the gene is expressed at sites of active cell type specification and neuronal differentiation. Genetic and functional analysis in vivo and in vitro is underway to determine the role of this factor, and its mode of interaction with nuclear regulatory proteins in vertebrate CNS development.
Experimental procedures

General procedures
Standard molecular techniques were performed according to established protocols (Sambrook et al., 1989) .
Hybridization of mouse tissue sections
In situ hybridization of wholemount embryos and of tissue sections was essentially as described (Wilkinson, 1992) , with minor modifications (Malgaretti et al., 1997) .
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